IBDEI0A6 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13470,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13470,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,13470,1,5,0)
 ;;=5^Personal h/o Colon Polyps
 ;;^UTILITY(U,$J,358.3,13470,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,13471,0)
 ;;=V12.59^^86^788^46
 ;;^UTILITY(U,$J,358.3,13471,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13471,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,13471,1,5,0)
 ;;=5^Personal h/o Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,13471,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,13472,0)
 ;;=V45.81^^86^788^47
 ;;^UTILITY(U,$J,358.3,13472,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13472,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,13472,1,5,0)
 ;;=5^Personal h/o Coronary Bypass
 ;;^UTILITY(U,$J,358.3,13472,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,13473,0)
 ;;=V15.84^^86^788^48
 ;;^UTILITY(U,$J,358.3,13473,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13473,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,13473,1,5,0)
 ;;=5^Personal h/o Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,13473,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,13474,0)
 ;;=V15.85^^86^788^53
 ;;^UTILITY(U,$J,358.3,13474,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13474,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,13474,1,5,0)
 ;;=5^Personal h/o Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,13474,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,13475,0)
 ;;=V10.72^^86^788^51
 ;;^UTILITY(U,$J,358.3,13475,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13475,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,13475,1,5,0)
 ;;=5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,13475,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,13476,0)
 ;;=V15.3^^86^788^52
 ;;^UTILITY(U,$J,358.3,13476,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13476,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,13476,1,5,0)
 ;;=5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,13476,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,13477,0)
 ;;=V10.61^^86^788^26
 ;;^UTILITY(U,$J,358.3,13477,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13477,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,13477,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,13477,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,13478,0)
 ;;=V12.03^^86^788^27
 ;;^UTILITY(U,$J,358.3,13478,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13478,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,13478,1,5,0)
 ;;=5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,13478,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,13479,0)
 ;;=V10.82^^86^788^28
 ;;^UTILITY(U,$J,358.3,13479,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13479,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,13479,1,5,0)
 ;;=5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,13479,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,13480,0)
 ;;=V10.62^^86^788^30
 ;;^UTILITY(U,$J,358.3,13480,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13480,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,13480,1,5,0)
 ;;=5^Hx of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,13480,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,13481,0)
 ;;=V10.63^^86^788^29
 ;;^UTILITY(U,$J,358.3,13481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13481,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,13481,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,13481,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,13482,0)
 ;;=V11.2^^86^788^24
 ;;^UTILITY(U,$J,358.3,13482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13482,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,13482,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,13482,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,13483,0)
 ;;=V15.81^^86^788^40
 ;;^UTILITY(U,$J,358.3,13483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13483,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,13483,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,13483,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,13484,0)
 ;;=V10.43^^86^788^31
 ;;^UTILITY(U,$J,358.3,13484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13484,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,13484,1,5,0)
 ;;=5^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,13484,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,13485,0)
 ;;=V12.71^^86^788^32
 ;;^UTILITY(U,$J,358.3,13485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13485,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,13485,1,5,0)
 ;;=5^Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,13485,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,13486,0)
 ;;=V10.46^^86^788^33
 ;;^UTILITY(U,$J,358.3,13486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13486,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,13486,1,5,0)
 ;;=5^Hx of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,13486,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,13487,0)
 ;;=V11.0^^86^788^34
 ;;^UTILITY(U,$J,358.3,13487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13487,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,13487,1,5,0)
 ;;=5^Hx of Schizophrenia
 ;;^UTILITY(U,$J,358.3,13487,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,13488,0)
 ;;=V10.83^^86^788^35
 ;;^UTILITY(U,$J,358.3,13488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13488,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,13488,1,5,0)
 ;;=5^Hx of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,13488,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,13489,0)
 ;;=V15.1^^86^788^36
 ;;^UTILITY(U,$J,358.3,13489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13489,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,13489,1,5,0)
 ;;=5^Hx of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,13489,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,13490,0)
 ;;=V15.82^^86^788^38
 ;;^UTILITY(U,$J,358.3,13490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13490,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,13490,1,5,0)
 ;;=5^Hx of Tobacco Use (not current)
 ;;^UTILITY(U,$J,358.3,13490,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,13491,0)
 ;;=V12.01^^86^788^37
 ;;^UTILITY(U,$J,358.3,13491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13491,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,13491,1,5,0)
 ;;=5^Hx of TB
 ;;^UTILITY(U,$J,358.3,13491,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,13492,0)
 ;;=V13.01^^86^788^25
 ;;^UTILITY(U,$J,358.3,13492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13492,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,13492,1,5,0)
 ;;=5^Hx of Kidney Stones
 ;;^UTILITY(U,$J,358.3,13492,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,13493,0)
 ;;=V12.51^^86^788^39
 ;;^UTILITY(U,$J,358.3,13493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13493,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,13493,1,5,0)
 ;;=5^Hx of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,13493,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,13494,0)
 ;;=V17.89^^86^788^1
 ;;^UTILITY(U,$J,358.3,13494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13494,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,13494,1,5,0)
 ;;=5^Fam Hx Musculosk Dis
 ;;^UTILITY(U,$J,358.3,13494,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,13495,0)
 ;;=V12.54^^86^788^55
 ;;^UTILITY(U,$J,358.3,13495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13495,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,13495,1,5,0)
 ;;=5^Personal h/o TIA
 ;;^UTILITY(U,$J,358.3,13495,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,13496,0)
 ;;=V12.54^^86^788^54
 ;;^UTILITY(U,$J,358.3,13496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13496,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,13496,1,5,0)
 ;;=5^Personal h/o Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,13496,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,13497,0)
 ;;=V15.88^^86^788^50
 ;;^UTILITY(U,$J,358.3,13497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13497,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,13497,1,5,0)
 ;;=5^Personal h/o Fall(s)
 ;;^UTILITY(U,$J,358.3,13497,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,13498,0)
 ;;=V13.59^^86^788^23
 ;;^UTILITY(U,$J,358.3,13498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13498,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,13498,1,5,0)
 ;;=5^Hx Musculoskletl Dis
 ;;^UTILITY(U,$J,358.3,13498,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,13499,0)
 ;;=V15.52^^86^788^56
 ;;^UTILITY(U,$J,358.3,13499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13499,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,13499,1,5,0)
 ;;=5^Personal h/o Traum Brain Inj
 ;;^UTILITY(U,$J,358.3,13499,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,13500,0)
 ;;=V70.0^^86^789^1
 ;;^UTILITY(U,$J,358.3,13500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13500,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,13500,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,13500,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,13501,0)
 ;;=V77.91^^86^789^2
 ;;^UTILITY(U,$J,358.3,13501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13501,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,13501,1,5,0)
 ;;=5^Screen for High Cholesterol
 ;;^UTILITY(U,$J,358.3,13501,2)
 ;;=Screen for High Cholesterol^322093
 ;;^UTILITY(U,$J,358.3,13502,0)
 ;;=V76.44^^86^789^3
 ;;^UTILITY(U,$J,358.3,13502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13502,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,13502,1,5,0)
 ;;=5^Screen for Prostate CA
 ;;^UTILITY(U,$J,358.3,13502,2)
 ;;=Screen for Prostate CA^321548
 ;;^UTILITY(U,$J,358.3,13503,0)
 ;;=V74.5^^86^789^5
 ;;^UTILITY(U,$J,358.3,13503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13503,1,4,0)
 ;;=4^V74.5
 ;;^UTILITY(U,$J,358.3,13503,1,5,0)
 ;;=5^Screening for STD's
 ;;^UTILITY(U,$J,358.3,13503,2)
 ;;=Screening for STD's^295637
 ;;^UTILITY(U,$J,358.3,13504,0)
 ;;=V73.89^^86^789^4
 ;;^UTILITY(U,$J,358.3,13504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13504,1,4,0)
 ;;=4^V73.89
 ;;^UTILITY(U,$J,358.3,13504,1,5,0)
 ;;=5^Screening for HIV
 ;;^UTILITY(U,$J,358.3,13504,2)
 ;;=^295833
 ;;^UTILITY(U,$J,358.3,13505,0)
 ;;=919.1^^86^790^1
 ;;^UTILITY(U,$J,358.3,13505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13505,1,4,0)
 ;;=4^919.1
 ;;^UTILITY(U,$J,358.3,13505,1,5,0)
 ;;=5^Abrasion, Infected
 ;;^UTILITY(U,$J,358.3,13505,2)
 ;;=^275358
